Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1 Expression in an AhR-Independent Fashion
1 September 2010
By
Nevena Djuranovic
Read more about Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1 Expression in an AhR-Independent Fashion
Erika Terzuoli, Maura Puppo, Annamaria Rapisarda, Badarch Uranchimeg, Liang Cao, Angelika M. Burger, Marina Ziche, and Giovanni Melillo
Metalloporphyrin synergizes with ascorbic acid to inhibit cancer cell growth through fenton chemistry.
1 August 2010
By
Nevena Djuranovic
Read more about Metalloporphyrin synergizes with ascorbic acid to inhibit cancer cell growth through fenton chemistry.
Tian J, Peehl DM, Knox SJ.
HIF-2 deletion promotes Kras-driven lung tumor development
1 August 2010
By
Nevena Djuranovic
Read more about HIF-2 deletion promotes Kras-driven lung tumor development
Jolly Mazumdar, Michele M. Hickey, Dhruv K. Pant, Amy C. Durham, Alejandro Sweet-Cordero, Anil Vachani, Tyler Jacks, Lewis A. Chodosh, Joseph L. Kissil, M. Celeste Simon, and Brian Keith
Anti-tumor and radiosensitization activities of the iron chelator HDp44mT are mediated by effects on intracellular redox status.
1 August 2010
By
Nevena Djuranovic
Read more about Anti-tumor and radiosensitization activities of the iron chelator HDp44mT are mediated by effects on intracellular redox status.
Tian J, Peehl DM, Zheng W, Knox SJ.
Toxoplasma gondii Activates Hypoxia-inducible Factor (HIF) by Stabilizing the HIF-1 Subunit via Type I Activin-like Receptor Kinase Receptor Signaling
1 August 2010
By
Nevena Djuranovic
Read more about Toxoplasma gondii Activates Hypoxia-inducible Factor (HIF) by Stabilizing the HIF-1 Subunit via Type I Activin-like Receptor Kinase Receptor Signaling
Mandi Wiley, Kristin R. Sweeney, Denise A. Chan, Kevin M. Brown, Curtis McMurtrey, Eric W. Howard, Amato J. Giaccia, and Ira J. Blader
Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation.
1 July 2010
By
Nevena Djuranovic
Read more about Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation.
Wheeler SE, Suzuki S, Thomas SM, Sen M, Leeman-Neill RJ, Chiosea SI, Kuan CT, Bigner DD, Gooding WE, Lai SY, Grandis JR.
Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling and Up-regulation of Egr-1 in Hypoxic Macrophages*
1 July 2010
By
Nevena Djuranovic
Read more about Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling and Up-regulation of Egr-1 in Hypoxic Macrophages*
Yunlu Xu, Fatouma Toure, Wu Qu, Lili Lin, Fei Song, Xiaoping Shen, Rosa Rosario, Joel Garcia, Ann Marie Schmidt, and Shi-Fang Yan
Physiological hypoxia promotes lipid raft and PI3K-dependent activation of MAPK 42/44 in leukemia cells
1 May 2010
By
Nevena Djuranovic
Read more about Physiological hypoxia promotes lipid raft and PI3K-dependent activation of MAPK 42/44 in leukemia cells
Fiegl M, Samudio I, Mnjoyan Z, Korchin B, Fritsche H, Andreeff M.
Effect of lenalidomide on hypoxia-induced HIF-1 signaling and the invasive phenotype in epithelial solid tumor cells.
1 May 2010
By
Nevena Djuranovic
Read more about Effect of lenalidomide on hypoxia-induced HIF-1 signaling and the invasive phenotype in epithelial solid tumor cells.
L. Lu, P. Schafer, and J. B. Bartlett
Absence of functional EpoR expression in human tumor cell lines
1 May 2010
By
Nevena Djuranovic
Read more about Absence of functional EpoR expression in human tumor cell lines
Susan Swift, Aaron R. Ellison, Paul Kassner, Ian McCaffery, John Rossi, Angus M. Sinclair, C. Glenn Begley, and Steven Elliott